TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | -2 | -2 | 3 | 32 | 48 | 13 |
| S | %wins | 100 | 100 | 100 | 50 | 0 | 0 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/16 14:45 | 11/18/16 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Madigan John W | CA | D | S.d | -7,860 | 74.86 | 33 | -105 | -86 | 17 | D | -23 | -28 | -12 | -7 | 2 | 1 | -4 | -1 | -1 | 0 | -1 | -7 | |||
8/1/13 17:14 | 7/30/13 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Madigan John W | CA | D | S.d | -15,431 | 61.97 | 33 | -249 | -87 | 36 | D | 184 | 121 | 54 | 22 | 21 | 10 | 3 | -2 | 0 | -3 | -2 | 12 | 32 | 48 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |